Compare GNK & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNK | CERT |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2005 | 2020 |
| Metric | GNK | CERT |
|---|---|---|
| Price | $26.15 | $7.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $19.00 | $11.67 |
| AVG Volume (30 Days) | 250.4K | ★ 3.7M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.90% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 0.21 | N/A |
| Revenue | $342,054,000.00 | ★ $418,838,000.00 |
| Revenue This Year | $21.15 | $4.18 |
| Revenue Next Year | $1.41 | $5.39 |
| P/E Ratio | $124.95 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $15.56 | $4.45 |
| 52 Week High | $27.25 | $13.88 |
| Indicator | GNK | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 55.96 | 45.77 |
| Support Level | $22.78 | $6.57 |
| Resistance Level | $27.03 | $7.44 |
| Average True Range (ATR) | 0.74 | 0.37 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 73.79 | 22.86 |
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.